Knight Therapeutics Inc. (TSX:GUD)

Knight Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	578	536	541	584	630	696
Market Cap Growth	14.14%	-0.95%	-7.35%	-7.29%	-9.50%	-32.33%
Enterprise Value	451	418	455	466	510	337
Last Close Price	5.80	5.34	5.19	5.18	5.30	5.35
PE Ratio	58.06	123.63	-	-	40.16	16.54
Forward PE	80.00	157.06	79.24	-	82.43	-
PS Ratio	1.55	1.44	1.65	1.99	2.59	3.49
PB Ratio	0.73	0.67	0.72	0.71	0.75	0.79
P/TBV Ratio	1.34	1.26	1.43	1.44	1.51	1.07
P/FCF Ratio	80.99	15.84	15.45	13.86	15.44	-
P/OCF Ratio	63.72	14.76	15.05	12.97	14.11	-
EV/Sales Ratio	1.21	1.13	1.39	1.59	2.10	1.69
EV/EBITDA Ratio	8.95	7.46	8.55	11.38	15.73	113.34
EV/EBIT Ratio	-	56.47	71.47	-	-	-
EV/FCF Ratio	63.20	12.35	13.01	11.07	12.52	-
Debt / Equity Ratio	0.07	0.06	0.09	0.09	0.05	0.06
Debt / EBITDA Ratio	1.07	0.83	1.24	1.73	1.18	9.99
Debt / FCF Ratio	7.56	1.46	1.98	1.85	1.00	-
Asset Turnover	0.38	0.39	0.33	0.29	0.24	0.17
Inventory Turnover	1.74	2.02	1.91	1.89	1.99	1.85
Quick Ratio	2.01	2.57	2.35	2.08	2.16	4.28
Current Ratio	2.98	3.57	3.20	2.80	2.90	4.84
Return on Equity (ROE)	1.42%	0.56%	-2.14%	-3.58%	1.81%	3.53%
Return on Assets (ROA)	-0.05%	0.48%	0.40%	-1.04%	-0.79%	-1.40%
Return on Capital (ROIC)	-0.06%	0.56%	0.46%	-1.19%	-0.88%	-1.71%
Return on Capital Employed (ROCE)	-	0.90%	0.80%	-	-	-
Earnings Yield	1.91%	0.81%	-3.11%	-5.12%	2.49%	6.05%
FCF Yield	1.23%	6.31%	6.47%	7.22%	6.48%	-2.53%
Buyback Yield / Dilution	3.54%	5.61%	6.46%	7.74%	5.66%	5.82%

Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.